Stock comparison
Avanos Medical
Eli Lilly
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
AVNS
Avanos Medical
Market cap
$1.15B
Sector
Healthcare
LLY
Eli Lilly
Market cap
$1T
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | AVNS | LLY | Winner |
|---|---|---|---|
| Warren Buffett | 18F | 72B | LLY |
| Benjamin Graham | 30F | 86A | LLY |
| Philip Fisher | 24F | 86A | LLY |
| Peter Lynch | 2F | 74B | LLY |
| Joel Greenblatt | 0F | 78C | LLY |
| Charlie Munger | 18F | 85A | LLY |
| Terry Smith | 15F | 77C | LLY |
Side-by-side metrics
| Metric | AVNS | LLY |
|---|---|---|
| Market cap | $1.15B | $1T |
| P/E (TTM) | - | 36.6x |
| EV/EBIT | - | 34.1x |
| ROIC (TTM) | -6.03% | 32.06% |
| Gross margin | 48.55% | 83.51% |
| Net margin | -9.69% | 34.98% |
| Revenue CAGR 5y | -1.49% | 23.17% |
| EPS CAGR 5y | - | 40.81% |
| Debt / Equity | 0.2x | 1.4x |
| Dividend yield | 0.0% | 0.62% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
AVNS leads on
- EV/EBIT-vs 34.1x+159%
- P/E (TTM)-vs 36.6x+145%
- Debt / Equity0.2xvs 1.4x+87%
LLY leads on
- Net margin34.98%vs -9.69%+128%
- ROIC (TTM)32.06%vs -6.03%+119%
- Revenue CAGR 5y23.17%vs -1.49%+106%
- Dividend yield0.62%vs 0.0%+100%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.